左肺动脉异常起源于主动脉（AOLPA），是一...[详情]
2026年1月28日，诺华宣布其创新降脂药物英克司兰钠注射液（乐可为）获中国...[详情]
我来挑战
血栓栓塞性疾病是全球主要疾病之一，低分子肝素(low molecular weight heparins，LMWHs) 作为抗凝药物在预防和治疗血[详情]
成员数：20893
话题数：6392
回帖数：32837
From Race-Based to Equity-Informed Antihypertensive Medicati
[读者来信]Letter by Sun Regarding Article, "Nonculprit Vulnerable Plaq
[读者来信]Response by Maeng et al to Letters Regarding Article, "Noncu
[述评]When Do Clinical Trials Expire?: Reflections on Beta-Blocker
[述评]MANIFEST-US: When Electroporation Is Scaling Up.
[临床试验]Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardi
Long forms of cardiac troponin T for myocardial infarction d
Focus on acute coronary syndrome: mechanisms, diagnosis, man
New venues to study the effects of exercise on quality of li
Goodbye, Out With the Old and in With the New.
[综述]AI in Hypertensive Disorders of Pregnancy: Review.
[临床试验]Low Achieved Systolic Blood Pressure Related to Kidney Prote
"Shroud": Poetry and Seeing the Body After Death.
Audio Highlights: December 12, 2025.
JAMA.
Autonomy vs. Equity: NOS Episode 3.9.
[临床试验]Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple
[综述]Physiologic Pacing in Heart Failure.
